The novel heterocyclization of 5-(2-aminophenyl)-1Н-tetrazole with potassium ethylxanthogenate or carbon disulfide was proposed. The potassium salt of the tetrazolo [1,5-c] 
Abstract
The novel heterocyclization of 5-(2-aminophenyl)-1Н-tetrazole with potassium ethylxanthogenate or carbon disulfide was proposed. The potassium salt of the tetrazolo [1,5-c] quinazoline-5-thione was subsequently modified by alkylation with proper halogen derivatives to (tetrazolo [1,5-c]quinazolin-5-ylthio)alkyls, N,N-dialkylethylamines, 1-aryl-2-ethanones, 1-(alkyl) aryl-2-ethanols, carboxylic acids, and esters. The structures of all newly synthesized compounds were confirmed by FT-IR, UV-vis, LC-MS, 1 H, 13 C NMR, and elemental analysis data. The substances were screened for antibacterial and antifungal activities (100 µg) against Escherichia coli, Staphylococcus aureus, Enterobacter aerogenes, Entrococcus faecalis, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Candida albicans. Preliminary bioluminescence inhibition tests against Photobacterium leiognathi Sh1 showed that substances 5.2-5.4, 6.1, 7.1 with ethanone or carboxylic acid substituents showed toxicity against bacteria cells. The substances chosen by the US National Cancer Institute (NCI) were screened for their ability to inhibit 60 different human tumor cell lines, where 2-(tetrazolo [1,5-c] quinazolin-5-ylthio)-1-(4-tolyl)ethanone (5.2), 3-(tetrazolo [1,5-c] quinazolin-5-ylthio)propanoic and related 3-metyl-butanoic acids (6.2, 6.3) , and ethyl tetrazolo [1,5-c] quinazolin-5-ylthio)acetate (7.2) 
Introduction
Investigations for new effective and less toxic antimicrobials and anticancer agents are always up-to-date. The tetrazole derivatives are quite interesting objects for synthesis as well as for pharmacological screening. Despite the fact that they weren't found in the nature and were synthetically obtained, there are a lot of biologically active substances among their fused analogues [1] [2] [3] [4] [5] [6] [7] . We are concerned with tetrazolo [1,5-c] quinazoline derivatives, because only few substances with very insufficient evaluation of their biological properties are reported in literature (Scheme 1) [8] [9] [10] [11] [12] [13] [14] [15] [16] . It is known that the main way of the above-mentioned skeleton (1.1) formation is the cyclisation of 4-hydrazinoquinazolines (1.2) with nitritic acid or the reaction of 4-halogenоquinazolines (1.3) with sodium azide (Scheme 1). Also, 5-(2'-aminophenyl)-1Н-tetrazoles 1.4 are cyclized with acetic anhydride to result in proper tetrazolo [1,5-c] 
Sch. 1.
Synthesis of the tetrazolo [1,5-c] 
quinazolines
Sci Pharm. 2013; 81: Tetrazoloquinazolines are very attractive from the pharmacological point of view, because they are found to possess fungicide, pesticide, anti-allergic, bactericide, bronchodilator, antiulcer, anti-inflammatory, analgesic, and antihypertensive properties [9] . Thus, investigation of the 9-bromo/chloro-5-(morpholin-4-yl/piperidin-4-yl)-tetrazolo [1,5-c] quinazoline's (1) antimicrobial activity against Esherichia coli, E. faecalis, Pseudomonas aeruginosa, and Staphylococcus aureus revealed that the sensitivity of Gram positive bacteria to the compounds was higher than that of Gram negative bacteria ( Fig. 1 ) [11] . 5-Phenyltetrazolo [1,5-c] quinazoline (2) was effective against Staphylococcus aureus and Esherichia faecalis (MIC = 250 mg/L). Also, 9-bromo-5-(morpholin-4-yl)tetrazolo [1,5-c] quinazoline (1) demonstrated antitumor activity against leukemia L1210 and column cancer Caco-2 cell lines [12] . Besides, quinazoline derivatives are important and broadly explored the structural class of EGFR inhibitors, namely the first ones found: Erlotinib (OSI-774; CP-358, Tarceva®) and Gefitinib (ZD1839; Iressa®, ( Fig. 1 ) [17] . Also wellknown anticancer drugs are Cediranib (AZD2171, Recentin®), Lapatinib (GW-0572016; Tykerb®), Vandetanib (ZD6474; Zactima®), and Saracatinib (AZD0530) (Fig. 1 ) [18] [19] [20] [21] [22] [23] [24] [25] . Anticancer and antimicrobial quinazoline, tetrazolo [1,5-c] -and triazolo [1,5-с] quinazoline derivatives
Introduction of the sulfur atom in the 5 position of the tetrazolo [1,5-c] quinazoline nucleus could afford the broadening of the biological activity range. Moreover, our previous investigations in the series of similar condensed heterocycles, namely, 2-thio- [1, 2, 4] triazolo [1,5-c] quinazoline derivatives, showed that ( [1, 2, 4] triazolo [1,5-c] quinazolin-2-ylthio)carboxylic acids and amides (3) possessed antifungal activity against Candida albicans and Aspergillus niger [26, 27] . So, the aim of this work is the purposeful formation of the tetrazolo [1,5-c] quinazoline-5-thione skeleton, synthesis of its S-derivatives, and screening of their antibacterial, antifungal, and antitumor properties with subsequent docking studies of the most active ones. 
Sch. 2.
Synthesis of the tetrazolo [1,5-с] quinazoline-5-thione potassium salt and its S-derivatives
Results and Discussion

Chemistry
The tetrazolo [1,5-с] quinazoline (b) was obtained by the treatment of 4-hydrazinoquinazoline (а) with sodium nitrite in acetic acid at 0°С with subsequent nucleophilic degradation of its pyrimidine ring in the water solution of hydrochloric acid (1:1) to 5-(2'-aminophenyl)-1Н-tetrazole (c). The latter one (c) was cyclized with potassium ethylxanthoganate in 2-propanol or with carbon disulfide in equimolar potassium ethoxide to produce the tetrazolo [1,5-с] quinazoline potassium salt 1 (Scheme 2).
Alkylation of the starting substance 1 with the methyl-/phenethyl-halogenides resulted in corresponding substances 2.1 and 2.2 at room temperature after 30 minutes. thio]tetrazolo [1,5-c] quinazoline (2.3) was synthesized by the refluxing of compound 1 with unsymmetrical 1-bromo-3-chloropropane in 2-propanol. ethylthio]tetrazolo [1,5-c] quinazolines (3.1-3.5) were obtained by the treatment of salt 1 with appropriate 2-chloro-ethylamino(hetaryl)dialkyls hydrochlorides in equimolar potassium ethoxide (Scheme 2) . The corresponding 2-(tetrazolo [1,5-с] quinazolin-5-ylthio)ethanones (5.1-5.4) , alcohols (4.1, 4.2), and carboxylic acid esters (7.1-7.8) It is known that tetrazoloquinazolines are capable of tetrazole-azide-azomethine tautomeric transformations due to the electrono-donative influence of the condensed quinazoline ring to the tetrazole one [15] . FT-IR spectral analysis of the synthesized substances (3.1-3.5) in solid form and in chloroform solution showed the absence of the azide group vibration at 2100 сm −1 , which indicates the prevalence of the tetrazole form of the molecule. The low intensity vibrations of the azide tautomer at 2145 сm −1 and its overtone at 2198 сm −1 were detected when trifluoroacetic acid was added to the substances (3.1-3.5) in chloroform solution.
In the 1 Н NMR-spectra, the tetrazolo [1,5-c] quinazoline system of all synthesized substances was characterized according to the proposed structure and available literature data: the one-proton doublet of Н-10 at 8.34-8.55 ppm, Н-7 and Н-9 as the two-proton multiplet at 8.06-7.74 , and H-8 as the one-proton triplet at 7.60-7.97 ppm were observed [8] . The signal of SCH 3 was seen in a strong field of spectra at 2.86 ppm as the threeproton singlet for substance 2.1. The proton of the OH group was shown as a wide oneproton singlet at 14.39 ppm for alcohol 4.1 and at 13.54-12.35 ppm for acids 6.1-6.2, and shifted to a stronger field to 11.68 ppm for 4.2. The signal of the SCH 2 -group appeared in a strong field of the spectra as the two-proton triplet at 3.72 ppm for 2.2, at 3.62 ppm for 2.3, and shifted to a low field as the two-proton singlet at 5.22-5.06 ppm for alcohols 4.1, 4.2, аnd to 4.72-3.40 ppm for ethanones 5.1-5.4, and was also observed at 4.85-4.26 ppm for acid 6.1 and acid esters 7.1, 7.3, 7.4, 7.8. The SCH-group was observed as the one-proton triplet at 5.17-5.03 ppm for 7.5-7.7 and as the one-proton singlet at 4.80 ppm for 7.2. The signals of aliphatic substituents of the synthesized substances were registered in a strong field (2.89-0.86 ppm) and aromatic substituent signals were observed in a low field (7.98-7.22 ppm) .
In
13 C NMR spectra of substances 7.2 and 7.6, the characteristic signal of the carboxylic group was registered at 170.55 ppm and 170.18 ppm respectively, and the carbonyl group of compound 5.4 at 191.50 ppm. The quinazoline С-5 was detected at 149.32-149.07 ppm, and the peak of the SСН 2 -group was registered at 38.80 ppm for 5.3, and at 49.87-47.84 ppm for 7.2 and 7.6, which definitely confirmed the tetrazolo [1,5-c] quinazoline-5-thione formation and S-regioselectivity of alkylation.
Pharmacology
Photobacterium leiognathi bioluminescence inhibition
The pharmacological investigations started from the estimation of cytotoxicity of newly synthesized ( [1, 2, 4] triazolo [1,5-c] quinazolin-2-ylthio)carboxylic acids by measuring the inhibition of the BL of Photobacterium leiognathi in acute (inhibiting BL, Table 1 ) and chronic action tests (inhibiting BL and growth, Table 2 ).
The acute action test revealed that substance 2.2 was practically toxic to bacteria at all concentrations. Substances 2.1, 2.3, 3.1, 3.3, 7.2, 7.4-7.7 had a moderately negative effect on bacteria BL, but compounds 3.2, 3.4, 4.2, 5.3, 7.1, 7.8 inhibited BL to 2.4% with the increase of their concentrations. The strongest negative influence was demonstrated by 5-(2-(piperidin-1-yl)ethylthio)tetrazolo [1,5-c] quinazoline (3.5), 1-phenyl-substituted ethanons (5.1-5.4) , and 2-(tetrazolo [1,5-c] quinazolin-5-ylthio)acetic acid (6.1).
According to the chronic action test, introduction of the methyl (2.1), chloroethyl (2.3), ethylacetate (7.1), methyl 2-(2,4-dichlorophenyl)acetate (7.6) , and methyl 4-methylbenzoate (7.8) groups led to the stimulation of growth and bioluminescence of bacteria (Table 2 ). There was practically no influence on the BL for the 5-(2-(pyrrolidin-1-yl)-ethylthio)tetrazolo [1,5-c] quinazoline (3.4) and ethyl 2-(tetrazolo [1,5-c] quinazolin-5-ylthio)-3-(m-tolyl)propanoate (7.7).
Tab. 1.
Values of BL in acute action test (%)
Compd.
It is worth mentioning that substances 2.1, 3.2, 3.3, 3.5, 5.4, and 7.3 showed the effect of the hormesis phenomenon (stimulation of activity with a lower concentration) for 0.025 and 0.1 mg/mL doses. Compounds 2.2, 3.1, 7.4, 7.5 possessed moderate inhibition. The highest toxicity (inhibition Bl and growth to 0%) was shown by 4-nitro-2-((tetrazolo [1,5-c] 
Thus, the SAR study revealed that the introduction of the aliphatic acid ester group resulted in the initiation of luminescent bacteria growth in the chronic test. But replacement of the alkyl group with carboxylic acid or the aromatic acid ester, 2-methyl-4-nitrophenol and ethanone substituents in the 5 th position of the 5-thio-tetrazolo [1,5-c] 
Antimicrobial and antifungal activities
All of the newly synthesized compounds were evaluated for their in vitro antibacterial activity against Gram positive bacteria (Staphylococcus aureus, Enterococcus faecalis), Gram negative bacteria (Enterobacter aerogenes, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae), and antifungal properties against Candida albicans. The agar-diffusion method was used for the determination of preliminary activity compared to well-known reference antimicrobials. All of the compounds were dissolved in DMSO in a concentration of 100 µg/disk, using inhibition zone diameter (IZD, mm) as a measure for the antimicrobial activity ( Table 3 ).
The SAR determined that the introduction of the chloropropyl substituent in substance 2.3 was essential for its antifungal activity against Candida albicans like Nystatin action in the same concentration, but wasn't enough to possess antibacterial properties. Replacing the alkyl substituent by ethylaminodialkyl for substances 3.1-3.3 broadened the range of their antimicrobial activity. Also, shortening of the dialkylamino fragment of substances 3. Thus, the most active antimicrobials were found to be N, [1,5-c] 
Anticancer assay for preliminary in vitro testing
Among all of the newly synthesized compounds, only substances 2. Considering non-small-cell lung, colon cancer, melanoma, and ovarian cancer, they were practically insensitive to the synthesized substances except for the demonstration of the light antitumor activity by 1-(4-methoxyphenyl)-2-(tetrazolo [1,5- So, according to the SAR, introduction of the (4-tolyl)ethanone (5.2), acid (6.2, 6.3), and ester (7.1) fragments into the molecule of synthesized compounds imparted them the lethal activity against acute lymphoblastic leukemia CCRF-CEM cell line, among which ethyl 2-(tetrazolo [1,5-c] quinazolin-5-ylthio)acetate (7.1) was the most active. The substitution of the 4-methyl group of substance 5.2 with the 2,5-dimethoxy group for 5.4 changedthe range of its antitumor activity greatly to the widest moderate one among all investigated compounds with the best results inhibiting the CNS cancer SNB-75 cell line. But, unfortunately all of these compounds haven't satisfied the predetermined threshold inhibition criteria to progress to the 5-dose screen, which was designed to efficiently capture compounds with antiproliferate activity.
Docking, scoring, and visual inspection of synthesized substances into the ATP binding site of EGFR
To help us understand the anticancer activity of the observed compounds and guide further SAR studies, molecular docking of compounds 2.1, 2.2, 5.1-5.4, 6.1-6.3, and 7.1 into the ATP binding site of EGFR (2ITY.pdb) was performed [31] . The crystal structure of the enzyme with Gefitinib was obtained from the protein data bank [32] . The selected molecular targets cover some of the basic molecular mechanisms of antitumor effects. Also, the choice of the biological target was due to the literature data on the mechanism of action of 4-R-anilinoquinazolines -known anticancer products [17] .
Research was conducted by flexible molecular docking as an approach to finding molecules with the affinity for a specific biological target using the software package OpenEye, including related utilities: Fred Receptor2.2.5, Vida4. 1.1, Flipper, Babel3, Omega2.4.3, and Fred2.2.5 [33] .
According to Consensus score, compound 6.2 showed the highest affinity for EGFR, but was still lower compared to other known drugs (Gefitinib, Lapatinib). The calculated values are presented in Table 5 . Molecular docking with visual inspection indicated that compound 6.2 was nicely bound to the EGFR kinase with a hydrogen bond (marked by black color line): N···NH/Met 793 (distance 2.20 Å), while Gefitinib had the same but a shorter hydrogen bond (distance 1.72 Å) (Fig.2) . a b Thus, after comparing the docking mode, it could be postulated that the designed compounds might act on the same enzyme target where Gefitinib acted.
Conclusions
The efficient and general procedure for the synthesis of the novel tetrazolo [1,5-c] quinazoline-5-thione potassium salt 1 via cyclization of 5-(2'-aminophenyl)-1Н-tetrazole with potassium ethylxanthogenate in 2-propanol, or with carbon disulfide in potassium ethoxide solution, has been developed. The products of the alkylation of substance 1 with proper halogenoalkyls, 2-chloro-ethylamino(hetaryl)dialkyls, halogenoethanons, halogenoalcohols, halogenocarboxylic acids, and their esters were elucidated by FT-IR, LC-MS, 1 H, 13 C NMR, and elemental analysis data. The subsequent screening for antibacterial and antifungal activities in the concentration 100 µg revealed that the most active substances were N, N-dimethyl-(3.1), N,N-diethyl-(3.2) , N,N-di(isopropyl)-2-(tetrazolo [1,5-c] quinazolin-5-ylthio)ethanamine (3.3) , and 1-(4-methoxyphenyl)-2-(tetrazolo [1,5-c] quinazolin-5-ylthio)-ethanone (5.3). The SAR revealed that shortening of the dialkylamino fragment of substances 3.1-3.3 leads to a moderate decrease in antimicrobial activity against Enterococcus faecalis, and otherwise leads to an increase in activity against Staphylococcus aureus and Escherichia coli, and antifungal activity against Candida albicans. Introduction of the 4-methoxyphenyl group at 5 position of tetrazolo [1,5-c] quinazoline-5-thione (5.3) resulted in the synthesis of the best antimicrobial agent among all investigated substances that even moderately inhibited the growth of Pseudomonas aeruginosa and Klebsiella pneumoniae. Preliminary BL inhibition tests against Photobacterium leiognathi Sh1 showed that substances (5.2-5.4, 6.1, 7.1) with ethanon or carboxylic acid substituents had toxicity against bacteria cells. Thus, screening of the antitumor activity showed that in the concentration 1.0 µM 2-(tetrazolo [1,5-c] quinazolin-5-ylthio)-1-(4-tolyl)-ethanone (5.2), 3-(tetrazolo [1,5-c] quinazolin-5-ylthio)propanoic and 3-methyl-butanoic acids (6.2, 6.3) , and ethyl tetrazolo [1,5-c] quinazolin-5-ylthio)acetate (7.1) exhibited lethal activity against the acute lymphoblastic leukemia CCRF-CEM cell line, and substances 5.2 and 6.3 exhibited moderate anticancer properties against the leukemia MOLT-4 and HL06-(TB) cell lines. The 1-(2,5-dimethoxyphenyl)-2-(tetrazolo- [1,5-c] quinazolin-5-ylthio)ethanone 5.4 demonstrated the widest range of antitumor activity, inhibiting some cancer cell lines of almost all types with the best negative influence on the CNS cancer cell line SNB-75. So, the introduction of the molecules 3-propanoic and 3-methyl-butanoic acid (6.2, 6.3) , ethyl acetate (7.2), and (4-methoxyphenyl)ethanone (5.3) fragments were the best choice for possessing anticancer activities. Although the results of the antimicrobial activity are not very potent, the anticancer results are quite promising. Compared to the docking mode, it could be assumed that the synthesized substances might act on the ATP binding site of EGFR like Gefitinib does. And they could be used for advanced QSAR analysis based on in vitro biological activity investigations for the further purposeful optimization of the leading compounds in the more effective antimicrobials because of the ever-mounting problem of microorganisms' resistance as well as novel anticancer agents.
Experimental
Melting points were determined in open capillary tubes in a Thiele's apparatus and were uncorrected. The elemental analyses (C, H, N, S) were performed using the ELEMENTAR vario EL cube analyzer. UV-vis spectra (190-400 nm) were recorded on the Analytic Jena UV-vis spectrophotometer Specord 200 in methanol. The IR spectra (4000-600 cm −1 ) were recorded on a Bruker ALPHA FT-IR spectrometer using a module ATR eco ZnSe.
1 H NMR spectra (400 MHz and 500 MHz) were recorded on the Varian-Mercury 400 and Bruker Avance DRX-500 spectrometers with SiMe 4 as the internal standard in DMSO-d 6 solution. The LC-MS was recorded using a chromatography/mass spectrometric system which consisted of the high-performance liquid chromatograph "Agilent 1100 Series" equipped with the diode-matrix and mass-selective detector "Agilent LC/MSD SL" (atmospheric pressure chemical ionization -APCI). The purity of all obtained compounds was checked by 1 H NMR and LC-MS.
Tetrazolo [1,5-c] quinazoline (b) and 5-(2-aminophenyl)-1Н-tetrazole (c) were obtained by the reported in literature procedures [10] .
Other starting materials and solvents were obtained from commercially available sources and used without additional purification.
General Procedure for the Synthesis of Tetrazolo[1,5-c]quinazolin-5(1H)-thione Potassium Salt (1)
Potassium O-ethylxanthogenate (6.2 mmol) was added to the solution of 5-(2'-aminophenyl)-1Н-tetrazole c (6.2 mmol) in 2-propanol (10 mL). The resulting mixture was refluxed for 2 h. After cooling to room temperature, the crystalline precipitate was filtered and dried.
Potassium salt of Tetrazolo [1,5-c]quinazoline-5(1H)-thione (1) Yellow solid in 65.60% yield, mp 240-245°C. 1 H NMR (500 MHz): δ (ppm) 8.20 (d, J = 7.78 Hz, 1H, 7.69 (dd, J = 8.22, 7.12 Hz, 1H, 7.56 (t, J = 8.34 Hz, 1H, 7.36 (t, J = 7.45 Hz, 1H, . IR (cm −1 ): 1621 , 1566 , 1504 , 1472 , 1442 , 1358 , 1323 , 1314 , 1302 , 1253 , 1211 , 1136 , 1113 , 1103 , 1040 , 1006 , 985, 971, 925, 851, 767, Sci Pharm. 2013 81: 15-42 716, 671, 631, 607. UV (nm): 213, 234, 368. Anal. Calcd. for C 8 H 5 N 5 S: C, 47.28; H, 2.48; N, 34.46; S, 15.78. Found: C, 47.25; H, 2.53; N, 34.45; S, 15.75 .
General Procedure for the Synthesis of 5-(alkylthio)tetrazolo[1,5-c]quinazolines (2.1-2.3)
Proper chloroalkane(phenethyl) (4.4 mmol) was added to the suspension of potassium salt of tetrazolo [1,5-c] quinazolin-5(1H)-thione 1 (0.94 g, 4 mmol) in 15 mL of 2-propanol. The resulting mixture was refluxed for 30 minutes. After cooling, the precipitate was filtered out, washed with water, recrystallized from 2-propanol, and dried. [1,5-c] quinazoline (2.1) White solid in 80.55% yield, mp 158-160°C.
5-(Methylthio)tetrazolo
1 H NMR (400 MHz): δ (ppm) 8.51 (d, J = 7.20 Hz, 1H, 2H, 9), 7.80 (t, J = 6, 57 Hz, 1H, 2.86 (s, 3H, CH 3 ) . IR (cm −1 ): 3383, 2973 , 2917 , 2849 , 1725 , 1586 , 1516 , 1486 , 1472 , 1446 , 1379 , 1311 , 1251 , 1208 , 1156 , 1135 , 1101 H, 3.25; N, 32.24; S, 14.76. Found: C, 49.79; H, 3.23; N, 32.21; S, 14.79. 5-(Phenethylthio) tetrazolo [1,5-c] quinazoline (2.2) Light-brown solid in 70.65% yield, mp 118-120°C.
1 H NMR (400 MHz): δ (ppm) 8.50 (d, J = 7.71 Hz, 1H, 8.06 (d, J = 7.85 Hz, 1H, 8.00 (t, J = 7.56 Hz, 1H, 7.81 (t, J = 6.86 Hz, 1H, 7.41 (d, J = 6.47 Hz, 2H, 5), 7.36 (t, J = 6.59 Hz, 2H, 6), 1H, , 3026, 2921, 2850, 1951, 1876, 1723, 1619, 1586, 1561, 1487, 1473, 1451, 1400, 1382, 1321, 1277, 1262, 1230, 1214, 1162, 1138, 1108, 1072, 1036, 981, 967, 912,848, 828, 773, 759, 712, 695, 642 , 4.26; N, 22.78; S, 10.43. Found: C, 62.54; H, 4.28; N, 22.74; S, thio]tetrazolo [1,5-c] quinazoline (2.3) Light-brown solid in 58.09% yield, mp 76-78°C. 1 H NMR (400 MHz): δ (ppm) 8.52 (d, J = 7.81 Hz, 1H, 8.02 (m, 2H, 9), 7.82 (t, J = 7.24 Hz, 1H, 3096, 3066, 3041, 3016, 2945, 2913, 2848, 1615, 1585, 1557, 1488, 1472, 1445, 1378, 1351, 1322, 1310, 1263, 1210, 1162, 1136, 1100, 1076, 1033, 1022, 967, 951, 875, 861, 799, 772, 712, 695, 683, 641, 631, 604 3.60; N, 25.03; S, 11.46. Found: C, 47.20; H, 3.63; N, 25.06; S, 11.44 . To a solution of triethylamine 0.83 mL (6 mmol) in 20 mL of dioxane was added an appropriate hydrochloride chloroethyl(hetaryl)amine (6 mmol) and potassium salt of tetrazolo [1,5-c] quinazolin-5(1H)-thione 1 2.0 g (6 mmol).The mixture was refluxed for 3 h. After cooling, the precipitate was filtered out, washed with water, recrystallized from 2-propanol, and dried. , 5.77; N, 26.73; S, 10.20. Found: C, 57.27; H, 5.79; N, 26.71; S, 10.24 .
General Procedure for the Synthesis of alcohols 4.1 4.2)
To a suspension of tetrazolo [1,5-c] quinazolin-5(1H)-thione, potassium salt 1 0.95 g (4 mmol) in 10 mL of 2-propanol was added appropriate chloroalcohol (4.4 mmol) in 20 mL of propan-2-ol. The mixture was refluxed for 3 h. After cooling, the precipitate was filtered out, washed with water, recrystallized from 2-propanol, and dried. [1,5-c] 3236, 3220, 3180, 3142, 3108, 3077, 3031, 2996 , 2927 , 2761 , 1753 , 1630 , 1593 , 1557 , 1537 , 1519 , 1364 , 1316 , 1290 , 1273 , 1229 , 1055 H, 3.67; N, 28.32; S, 12.97. Found: C, 48.60; H, 3.65; N, 28.35; S, 13. 99. [1,5-c] 3111, 2917, 2850, 1615, 1589, 1521, 1489, 1454, 1440, 1403, 1380, 1334, 1291, 1279, 1246, 1233, 1172, 1148, 1128, 1111, 1079, 1051, 1023, 972, 936, 908, 883, 843, 825, 780, 742, 713, 681, 669, 661, 639 To a solution of tetrazolo [1,5-c] quinazolin-5(1H)-thione potassium salt 1 1.0 g (4 mmol) in 5 mL of water was added the solution of appropriate chloroethanones (4.4 mmol) in 5 mL of 2-propanol. The resulting mixture was heated for 3 h. After cooling, the precipitate was filtered out, washed with water, recrystallized from 2-propanol, and dried. [1,5-c] 8.18 (m, 2H, 9), 7.92 (t, J = 7.67 Hz, 1H, 7.78 (qd, J = 7.67 Hz, 2H, 6), 7.65 (t, J = 6.76 Hz, 3H, 4, 5) , 5.22 (s, 2H, SCH 2 ) . IR (cm −1 ): 3061, 3036, 3004, 2957, 2916, 2848, 1997, 1961, 1923, 1882, 1843, 1675, 1619, 1586, 1562, 1536, 1492, 1478, 1448, 1381, 1326, 1293, 1276, 1214, 1195, 1186, 1164, 1106, 1079, 1036, 993, 981, 969, 884, 787, 770, 755, 714, 688, 649, 629 N 5 OS: C, 59.80; H, 3.45; N, 21.79; S, 9.98. Found: C, 59.84; H, 3.41; N, 21.77; S, 9.95 . the average diameter of inhibition zones diameters (IZD) of bacterial or fungal growth around the discs in mm.
2-(Tetrazolo
4-Nitro-2-[(tetrazolo
1-Phenyl-2-(tetrazolo
Antitumor activity
The primary anticancer assay was performed against the human tumor cell lines panel derived from nine neoplastic diseases, in accordance with the protocol of the Drug Evaluation Branch, National Cancer Institute, Bethesda [28] [29] [30] . The human tumor cell lines of the cancer screening panel were grown in RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. For a typical screening experiment, cells were inoculated in 96 well microtiter plates in 100 mL assay volume, at plating densities ranging from 5000 to 40000 cell/well. After cell inoculation, the microtiter plates were incubated at 37°C under an atmosphere of 5:95 CO 2 :air (v/v) at 100% relative humidity, for 24 h prior to the addition of drugs under assessment. Following drug addition (1 µM), the plates were incubated for an additional 48 h, under the same conditions. Sulforhodamine B (SRB) solution (100 µL, 0-4% w/v in 1% aq. acetic acid) was added to each well and plates were incubated for 10 min at room temperature. The percentage growth was evaluated spectrophotometrically versus the controls not treated with test agents.
Docking, scoring, and visual inspection of synthesized substances into ATP binding site of EGFR
Research was conducted by flexible molecular docking, as an approach for finding molecules with affinity for a specific biological target using the software package OpenEye, including related utilities: Fred Receptor2.2.5, Vida4. 1.1, Flipper, Babel3, Omega2.4.3, and Fred2.2.5 [33] . The crystal structure of the enzyme EGFR (2ITY.pdb) with Gefitinib was obtained from the protein data bank [32] .
The methodology of research consisted of the following steps:
o generation of R-, S-and cis-, trans-isomers of ligands (the studied compounds and relevant drugs, program Flipper), which allowed the production isomer's range of studied compounds; o generation of 3D-structure of the obtained isomeric forms -molecular modelling (Hyper Chem 7.5) using the method of molecular mechanics (MM +) and semiempirical quantum mechanical method with Polak-Ribiere algorithm (PM3);
o generation of conformations of ligands (Omega2. 4.3) . The number of conformations obtained wasn't significant due to the further selection by program Fred2.2.5 most optimal conformer; o carrying out molecular docking (Fred2.2.5).
A number of scoring functions (Shapegauss, PLP, Chemgauss2, Chemgauss3, Chemscore, OEChemscore, Screenscore, CGO, CGT, Zapbind, Consensus Score) was obtained as a result of the studies, values of which assess specific characteristics of the ligand-protein complex, indicating the possibility of their matching.
